S Cuzzocrea Selected Research

S Cuzzocrea Research Topics

Disease

33	Inflammation (Inflammations) 10/2017 - 02/2000
15	Necrosis 03/2011 - 09/2000
14	Ischemia 02/2010 - 01/2000
13	Shock 06/2007 - 01/2000
12	Pleurisy (Pleuritis) 10/2010 - 02/2000
12	Reperfusion Injury 02/2010 - 01/2000
9	Lung Injury 10/2010 - 02/2000
8	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 11/2007
8	Experimental Arthritis 11/2008 - 02/2000
8	Colitis 11/2008 - 09/2000
8	Multiple Organ Failure (MODS) 06/2002 - 03/2000
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2009 - 09/2000
6	Arthritis (Polyarthritis) 10/2010 - 02/2000
4	Edema (Dropsy) 01/2016 - 03/2001
4	Body Weight (Weight, Body) 02/2005 - 10/2000
3	Neoplasms (Cancer) 09/2022 - 01/2010
3	Myelitis 10/2017 - 11/2007
3	Alzheimer Disease (Alzheimer's Disease) 03/2016 - 01/2010
3	Pneumonia (Pneumonitis) 10/2010 - 07/2001
3	Rheumatoid Arthritis 01/2009 - 12/2001
3	Periodontitis 02/2007 - 04/2004
3	Hemorrhage 12/2002 - 01/2001
3	Hemorrhagic Shock 12/2002 - 01/2001
3	Peritonitis 06/2002 - 01/2001
3	Weight Loss (Weight Reduction) 11/2001 - 09/2000
3	Diarrhea 01/2001 - 09/2000
3	Brain Injuries (Brain Injury) 11/2000 - 07/2000
2	Brain Diseases (Brain Disorder) 01/2022 - 01/2010
2	Neuroinflammatory Diseases 01/2020 - 01/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 01/2010

Drug/Important Bio-Agent (IBA)

15	CarrageenanIBA 01/2016 - 02/2000
14	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2010 - 02/2000
12	Peroxynitrous Acid (Peroxynitrite)IBA 10/2017 - 01/2000
9	3-nitrotyrosineIBA 01/2016 - 08/2000
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 02/2001
8	MelatoninIBA 10/2017 - 01/2000
8	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2017 - 11/2000
8	Peroxidase (Myeloperoxidase)IBA 07/2007 - 02/2000
8	tempolIBA 01/2001 - 02/2000
7	CytokinesIBA 10/2017 - 10/2001
7	EnzymesIBA 06/2013 - 09/2000
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2010 - 03/2001
7	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2001 - 06/2000
6	Proteins (Proteins, Gene)FDA Link 10/2017 - 01/2010
6	Superoxides (Superoxide)IBA 01/2010 - 11/2000
6	Interleukin-1beta (Interleukin 1 beta)IBA 10/2009 - 02/2001
6	DinitrobenzenesIBA 02/2003 - 09/2000
6	Sulfonic AcidsIBA 02/2003 - 09/2000
6	Malondialdehyde (Propanedial)IBA 11/2001 - 02/2000
6	Poly Adenosine Diphosphate RiboseIBA 08/2001 - 04/2000
6	Ligases (Synthetase)IBA 08/2001 - 04/2000
5	Pharmaceutical PreparationsIBA 06/2016 - 05/2005
5	P-SelectinIBA 10/2009 - 06/2000
5	Oxygen (Dioxygen)IBA 01/2008 - 03/2000
5	Free RadicalsIBA 01/2008 - 03/2001
5	Oxidants (Oxidizing Agents)IBA 01/2008 - 08/2000
5	2,4-dinitrofluorobenzene sulfonic acidIBA 02/2003 - 09/2000
5	ZymosanIBA 06/2002 - 03/2000
5	DNA (Deoxyribonucleic Acid)IBA 08/2001 - 09/2000
4	Neuroprotective AgentsIBA 01/2020 - 01/2011
4	Tyrosine Kinase InhibitorsIBA 06/2016 - 07/2000
4	NitritesIBA 02/2010 - 06/2000
4	CreatinineIBA 02/2010 - 04/2000
4	Hydroxyl RadicalIBA 01/2010 - 03/2001
4	Nitric Oxide Synthase (NO Synthase)IBA 04/2004 - 11/2000
4	imisopasem manganeseIBA 04/2003 - 02/2001
4	Superoxide DismutaseIBA 12/2001 - 01/2001
4	Acetylcysteine (Siran)FDA LinkGeneric 07/2001 - 07/2000
4	Biological ProductsIBA 01/2001 - 02/2000
3	NAD (NADH)IBA 01/2022 - 11/2000
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016 - 02/2008
3	Freund's AdjuvantIBA 10/2010 - 12/2000
3	Dinoprostone (PGE2)FDA Link 10/2010 - 02/2001
3	Bleomycin (Blenoxane)FDA LinkGeneric 10/2010 - 02/2005
3	Collagen Type II (Type II Collagen)IBA 10/2010 - 12/2000
3	EmulsionsIBA 10/2010 - 12/2000
3	Urea (Carbamide)FDA LinkGeneric 02/2010 - 04/2000
3	EndotoxinsIBA 11/2008 - 06/2000
3	Etanercept (Enbrel)FDA Link 07/2008 - 02/2007
3	Inflammation MediatorsIBA 11/2007 - 03/2001
3	NitratesIBA 11/2006 - 06/2000
3	Interleukin-6 (Interleukin 6)IBA 02/2003 - 02/2001
3	CalpainIBA 06/2001 - 12/2000
3	acetylleucyl-leucyl-norleucinalIBA 04/2001 - 12/2000
2	LigandsIBA 09/2022 - 03/2011
2	AntioxidantsIBA 01/2022 - 03/2001
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2017 - 10/2010
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2017 - 10/2010
2	EicosanoidsIBA 03/2016 - 01/2016
2	lipoxin A4IBA 03/2016 - 01/2016
2	AcidsIBA 01/2011 - 04/2001
2	zileuton (Zyflo)FDA Link 10/2010 - 02/2008
2	LipopolysaccharidesIBA 10/2010 - 08/2001
2	EstersIBA 10/2010 - 01/2010
2	NF-kappa B (NF-kB)IBA 10/2009 - 01/2001

Therapy/Procedure

12	Therapeutics 01/2022 - 03/2000
4	Laminectomy 10/2017 - 11/2007
3	Ligation 02/2007 - 04/2004
3	Intradermal Injections 05/2005 - 12/2000
3	Resuscitation 12/2002 - 01/2001